{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:50:21Z","timestamp":1787730621462,"version":"build-2784847793"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Histochemica"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.acthis.2019.151499","type":"journal-article","created":{"date-parts":[[2019,12,28]],"date-time":"2019-12-28T00:03:20Z","timestamp":1577491400000},"page":"151499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of vildagliptin on vascular and fibrotic remodeling of myocardium in experimental diabetic cardiomyopathy"],"prefix":"10.1016","volume":"122","author":[{"given":"Ahmed A.M.","family":"Abdel-Hamid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa El-Din L.","family":"Firgany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acthis.2019.151499_bib0005","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.placenta.2016.10.016","article-title":"Pattern of adhesive molecules expression in placenta of non-complicated ART pregnancies","volume":"48","author":"Abdel-Hamid","year":"2016","journal-title":"Placenta"},{"issue":"4\u20135","key":"10.1016\/j.acthis.2019.151499_bib0010","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10735-015-9625-4","article-title":"Atorvastatin alleviates experimental diabetic cardiomyopathy by suppressing apoptosis and oxidative stress","volume":"46","author":"Abdel-Hamid","year":"2015","journal-title":"J. Mol. Histol."},{"issue":"1","key":"10.1016\/j.acthis.2019.151499_bib0015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/iep.12261","article-title":"Correlation between testicular mast cell count and spermatogenic epithelium in non-obstructive azoospermia","volume":"99","author":"Abdel-Hamid","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"6","key":"10.1016\/j.acthis.2019.151499_bib0020","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10735-018-9801-4","article-title":"Favorable outcomes of metformin on coronary microvasculature in experimental diabetic cardiomyopathy","volume":"49","author":"Abdel-Hamid","year":"2018","journal-title":"J. Mol. Histol."},{"issue":"1","key":"10.1016\/j.acthis.2019.151499_bib0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.acthis.2018.10.005","article-title":"Correlation between pancreatic mast cells and the low grade inflammation in adipose tissue of experimental prediabetes","volume":"121","author":"Abdel-Hamid","year":"2019","journal-title":"Acta histochem."},{"issue":"4","key":"10.1016\/j.acthis.2019.151499_bib0030","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.acthis.2019.04.009","article-title":"Increased mast cell number is associated with a decrease in beta-cell mass and regeneration in type 2 diabetic rats","volume":"121","author":"Abdel-Hamid","year":"2019","journal-title":"Acta histochem."},{"issue":"6","key":"10.1016\/j.acthis.2019.151499_bib0035","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.acthis.2016.06.002","article-title":"Favorable outcomes of hydroxychloroquine in insulin resistance may be accomplished by adjustment of the endothelial dysfunction as well as the skewed balance of adipokines","volume":"118","author":"Abdel-Hamid","year":"2016","journal-title":"Acta Histochem."},{"issue":"7","key":"10.1016\/j.acthis.2019.151499_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102374","article-title":"Combined vildagliptin and metformin exert better cardioprotection than monotherapy against ischemia-reperfusion injury in obese-insulin resistant rats","volume":"9","author":"Apaijai","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.acthis.2019.151499_bib0045","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1210\/en.2012-1262","article-title":"Cardioprotective effects of metformin and vildagliptin in adult rats with insulin resistance induced by a high-fat diet","volume":"153","author":"Apaijai","year":"2012","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.acthis.2019.151499_bib0050","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/bph.12176","article-title":"Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin-resistant rats","volume":"169","author":"Apaijai","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.acthis.2019.151499_bib0055","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10741-017-9666-8","article-title":"The influence of anti-hyperglycemic drug therapy on cardiovascular and heart failure outcomes in patients with type 2 diabetes mellitus","volume":"23","author":"Asleh","year":"2018","journal-title":"Heart Fail. Rev."},{"issue":"2","key":"10.1016\/j.acthis.2019.151499_bib0060","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5551\/jat.33225","article-title":"Heart failure as a comorbidity of diabetes: role of dipeptidyl peptidase 4","volume":"23","author":"Bando","year":"2016","journal-title":"J. Atheroscler. Thromb."},{"issue":"25","key":"10.1016\/j.acthis.2019.151499_bib0065","doi-asserted-by":"crossref","first-page":"e7213","DOI":"10.1097\/MD.0000000000007213","article-title":"Comparative safety for cardiovascular outcomes of DPP-4 inhibitors versus glimepiride in patients with type 2 diabetes: a retrospective cohort study","volume":"96","author":"Chin","year":"2017","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/j.acthis.2019.151499_bib0070","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1745-7254.2005.00090.x","article-title":"Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats","volume":"26","author":"Ding","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"issue":"4","key":"10.1016\/j.acthis.2019.151499_bib0075","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/iep.12237","article-title":"Physical training improves visceral adipose tissue health by remodelling extracellular matrix in rats with estrogen absence: a gene expression analysis","volume":"98","author":"Duarte","year":"2017","journal-title":"Int. J. Exp. Pathol."},{"issue":"2","key":"10.1016\/j.acthis.2019.151499_bib0080","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s40256-016-0208-x","article-title":"Cardiovascular safety of dipeptidyl-peptidase IV inhibitors: a meta-analysis of placebo-controlled randomized trials","volume":"17","author":"Elgendy","year":"2017","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.acthis.2019.151499_bib0085","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.lfs.2016.03.052","article-title":"Effects of dipeptidyl peptidase-4 (DPP-4) inhibition on angiogenesis and hypoxic injury in type 2 diabetes","volume":"154","author":"Fiordaliso","year":"2016","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.acthis.2019.151499_bib0090","doi-asserted-by":"crossref","first-page":"e8170","DOI":"10.1371\/journal.pone.0008170","article-title":"Regional gene expression of LOX-1, VCAM-1, and ICAM-1 in aorta of HIV-1 transgenic rats","volume":"4","author":"Hag","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.acthis.2019.151499_bib0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jphs.2017.08.005","article-title":"DPP-4 inhibition protects human umbilical vein endothelial cells from hypoxia-induced vascular barrier impairment","volume":"135","author":"Hashimoto","year":"2017","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.acthis.2019.151499_bib0100","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.118.11498","article-title":"DPP (Dipeptidyl peptidase)-4 inhibition potentiates the vasoconstrictor response to NPY (Neuropeptide Y) in humans during renin-angiotensin-aldosterone system inhibition","author":"Hubers","year":"2018","journal-title":"Hypertension (Dallas, Tex.: 1979)"},{"issue":"6","key":"10.1016\/j.acthis.2019.151499_bib0105","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/met.2014.0035","article-title":"Cardiovascular effects of incretin therapy in diabetes care","volume":"12","author":"Kim","year":"2014","journal-title":"Metab. Syndr. Relat. Disord."},{"issue":"9","key":"10.1016\/j.acthis.2019.151499_bib0110","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.003957","article-title":"Dipeptidyl peptidase-4 inhibitors and risk of heart failure in patients with type 2 diabetes mellitus: a population-based cohort study","volume":"10","author":"Kim","year":"2017","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.acthis.2019.151499_bib0115","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bcp.2017.08.021","article-title":"Dipeptidyl peptidase-4 independent cardiac dysfunction links saxagliptin to heart failure","volume":"145","author":"Koyani","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.acthis.2019.151499_bib0120","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/1479164116629352","article-title":"Effects of dipeptidyl peptidase-4 inhibitors on cardiac and endothelial function in type 2 diabetes mellitus: a pilot study","volume":"13","author":"Leung","year":"2016","journal-title":"Diab. Vasc. Dis. Res."},{"issue":"3","key":"10.1016\/j.acthis.2019.151499_bib0125","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2337\/db15-1224","article-title":"Inhibition of dipeptidyl peptidase-4 impairs ventricular function and promotes cardiac fibrosis in high fat-fed diabetic mice","volume":"65","author":"Mulvihill","year":"2016","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.acthis.2019.151499_bib0130","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/CIRCULATIONAHA.117.028136","article-title":"Cardiovascular actions and clinical outcomes with glucagon-like Peptide-1 receptor agonists and dipeptidyl Peptidase-4 inhibitors","volume":"136","author":"Nauck","year":"2017","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.acthis.2019.151499_bib0135","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1161\/CIRCRESAHA.118.312673","article-title":"Do DPP-4 inhibitors cause heart failure events by promoting adrenergically mediated cardiotoxicity? Clues from laboratory models and clinical trials","volume":"122","author":"Packer","year":"2018","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.acthis.2019.151499_bib0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12933-017-0648-x","article-title":"Have dipeptidyl peptidase-4 inhibitors ameliorated the vascular complications of type 2 diabetes in large-scale trials? The potential confounding effect of stem-cell chemokines","volume":"17","author":"Packer","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"issue":"6","key":"10.1016\/j.acthis.2019.151499_bib0145","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jchf.2017.12.016","article-title":"Worsening heart failure during the use of DPP-4 inhibitors: pathophysiological mechanisms, clinical risks, and potential influence of concomitant antidiabetic medications","volume":"6","author":"Packer","year":"2018","journal-title":"JACC Heart Fail."},{"issue":"6","key":"10.1016\/j.acthis.2019.151499_bib0150","first-page":"471","article-title":"DPP-4 inhibitors, heart failure and type 2 diabetes: all eyes on safety","volume":"5","author":"Paneni","year":"2015","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"10.1016\/j.acthis.2019.151499_bib0155","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1475-2840-13-92","article-title":"The dipeptidyl peptidase-4 inhibitor saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patients","volume":"13","author":"Poncina","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.acthis.2019.151499_bib0160","first-page":"595","article-title":"Effects of dipeptidyl Peptidase 4 inhibitors and sodium-glucose linked coTransporter-2 inhibitors on cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis","volume":"220","author":"Savarese","year":"2016","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.acthis.2019.151499_bib0165","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijcard.2014.12.017","article-title":"Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in diabetic patients: a meta-analysis","volume":"181","author":"Savarese","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.acthis.2019.151499_bib0170","first-page":"532","article-title":"Fluvastatin-induced reduction of oxidative stress ameliorates diabetic cardiomyopathy in association with improving coronary microvasculature","volume":"29","author":"Shida","year":"2014","journal-title":"Int. J. Exp. Pathol."},{"issue":"15","key":"10.1016\/j.acthis.2019.151499_bib0175","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/CIRCULATIONAHA.112.096479","article-title":"Dipeptidyl peptidase-4 modulates left ventricular dysfunction in chronic heart failure via angiogenesis-dependent and -independent actions","volume":"126","author":"Shigeta","year":"2012","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.acthis.2019.151499_bib0180","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/GME.0000000000000640","article-title":"Estrogen and DPP4 inhibitor, but not metformin, exert cardioprotection via attenuating cardiac mitochondrial dysfunction in obese insulin-resistant and estrogen-deprived female rats","volume":"23","author":"Sivasinprasasn","year":"2016","journal-title":"Menopause (New York, N.Y.)"},{"key":"10.1016\/j.acthis.2019.151499_bib0185","first-page":"44306","article-title":"DPP-4 inhibitor and estrogen share similar efficacy against cardiac ischemic-reperfusion injury in obese-insulin resistant and estrogen-deprived female rats","volume":"7","author":"Sivasinprasasn","year":"2017","journal-title":"Cardiovasc. Ther."},{"issue":"8","key":"10.1016\/j.acthis.2019.151499_bib0190","article-title":"Inhibition of dipeptidyl peptidase-4 ameliorates cardiac ischemia and systolic dysfunction by up-regulating the FGF-2\/EGR-1 pathway","volume":"12","author":"Suda","year":"2017","journal-title":"Int. J. Exp. Pathol."},{"issue":"2","key":"10.1016\/j.acthis.2019.151499_bib0195","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1530\/JOE-16-0406","article-title":"Vildagliptin and caloric restriction for cardioprotection in pre-diabetic rats","volume":"232","author":"Tanajak","year":"2017","journal-title":"J. Endocrinol."},{"issue":"Supplement 1","key":"10.1016\/j.acthis.2019.151499_bib0200","article-title":"Dipeptidyl peptidase-4 inhibition with linagliptin promotes angiogenesis\/vasculogenesis in the hearts of female diabetic db\/db mice","volume":"67","author":"Toedebusch","year":"2018","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.acthis.2019.151499_bib0205","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00125-007-0719-8","article-title":"Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy","volume":"50","author":"Van Linthout","year":"2007","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.acthis.2019.151499_bib0210","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.2337\/db12-1025","article-title":"Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP\/PKA\/Rho-dependent mechanism","volume":"62","author":"Wang","year":"2013","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.acthis.2019.151499_bib0215","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12933-017-0572-0","article-title":"The impact of DPP-4 inhibitors on long-term survival among diabetic patients after first acute myocardial infarction","volume":"16","author":"Wang","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"issue":"11","key":"10.1016\/j.acthis.2019.151499_bib0220","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1253\/circj.CJ-17-0240","article-title":"Effect of dipeptidyl peptidase-4 inhibitors on cardiovascular outcome and cardiac function in patients with diabetes and heart failure- insights from the Ibaraki cardiac assessment study-heart failure (ICAS-HF) registry","volume":"81","author":"Yamamoto","year":"2017","journal-title":"Circ. J."},{"issue":"5","key":"10.1016\/j.acthis.2019.151499_bib0225","first-page":"401","article-title":"The rat model of type 2 diabetic mellitus and its glycometabolism characters","volume":"52","author":"Zhang","year":"2003","journal-title":"J. Diabetes Res."},{"issue":"1","key":"10.1016\/j.acthis.2019.151499_bib0230","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12933-017-0512-z","article-title":"Incretin-based agents in type 2 diabetic patients at cardiovascular risk: compare the effect of GLP-1 agonists and DPP-4 inhibitors on cardiovascular and pancreatic outcomes","volume":"16","author":"Zhang","year":"2017","journal-title":"Cardiovasc. Diabetol."}],"container-title":["Acta Histochemica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065128119304891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065128119304891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T18:09:21Z","timestamp":1758737361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065128119304891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0065128119304891"],"URL":"https:\/\/doi.org\/10.1016\/j.acthis.2019.151499","relation":{},"ISSN":["0065-1281"],"issn-type":[{"value":"0065-1281","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of vildagliptin on vascular and fibrotic remodeling of myocardium in experimental diabetic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Acta Histochemica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acthis.2019.151499","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151499"}}